Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandrine Imbeaud

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
Nature Communications|April 8, 2024
Single-cell multiomics reveals the interplay of clonal evolution and cellular plasticity in hepatoblastomaAmélie Roehrig, Theo Z Hirsch, Aurore Pire, et al.
Human Molecular Genetics|December 17, 2021
Corrigendum to: DYRK1A interacts with the REST/NRSF-SWI/SNF chromatin remodelling complex to deregulate gene clusters involved in the neuronal phenotypic traits of Down syndromeAude-Marie Lepagnol-Bestel, Agnes Zvara, Gilles Maussion, et al.
Human Molecular Genetics|February 17, 2009
DYRK1A interacts with the REST/NRSF-SWI/SNF chromatin remodelling complex to deregulate gene clusters involved in the neuronal phenotypic traits of Down syndromeAude-Marie Lepagnol-Bestel, Agnes Zvara, Gilles Maussion, et al.
Nature Communications|May 19, 2026
Integrated genomic analyses identify oncogenic pathway interplay in hepatocarcinogenesis defining specific molecular subtypesLong Pan, Théo Z Hirsch, Jing Fang, et al.
Ebiomedicine|October 22, 2021
Release of infectious virus and cytokines in nasopharyngeal swabs from individuals infected with non-alpha or alpha SARS-CoV-2 variants: an observational retrospective studyBlandine Monel, Delphine Planas, Ludivine Grzelak, et al.
Nature Genetics|March 31, 2015
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targetsKornelius Schulze, Sandrine Imbeaud, Eric Letouzé, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2024
Mutational signature, cancer driver genes mutations and transcriptomic subgroups predict hepatoblastoma survivalAurore Pire, Theo Z Hirsch, Guillaume Morcrette, et al.
Hepatology (Baltimore, Md.)|June 18, 2019
Clinical Impact of Genomic Diversity From Early to Advanced Hepatocellular CarcinomaJean-Charles Nault, Yoann Martin, Stefano Caruso, et al.
Journal of Hepatology|February 7, 2026
Serum procalcitonin: A novel tumor biomarker for diagnosis and disease monitoring in fibrolamellar hepatocellular carcinomaJean-Charles Nault, Claudia Campani, Theo Z Hirsch, et al.
Medrxiv : the Preprint Server for Health Sciences|December 3, 2025
Serum Procalcitonin: A Novel Tumor Biomarker for Diagnosis and Follow-Up in Fibrolamellar Hepatocellular CarcinomaJean-Charles Nault, Claudia Campani, Theo Z Hirsch, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Nature Communications|April 8, 2024
Single-cell multiomics reveals the interplay of clonal evolution and cellular plasticity in hepatoblastomaAmélie Roehrig, Theo Z Hirsch, Aurore Pire, et al.
Human Molecular Genetics|December 17, 2021
Corrigendum to: DYRK1A interacts with the REST/NRSF-SWI/SNF chromatin remodelling complex to deregulate gene clusters involved in the neuronal phenotypic traits of Down syndromeAude-Marie Lepagnol-Bestel, Agnes Zvara, Gilles Maussion, et al.
Human Molecular Genetics|February 17, 2009
DYRK1A interacts with the REST/NRSF-SWI/SNF chromatin remodelling complex to deregulate gene clusters involved in the neuronal phenotypic traits of Down syndromeAude-Marie Lepagnol-Bestel, Agnes Zvara, Gilles Maussion, et al.
Nature Communications|May 19, 2026
Integrated genomic analyses identify oncogenic pathway interplay in hepatocarcinogenesis defining specific molecular subtypesLong Pan, Théo Z Hirsch, Jing Fang, et al.
Ebiomedicine|October 22, 2021
Release of infectious virus and cytokines in nasopharyngeal swabs from individuals infected with non-alpha or alpha SARS-CoV-2 variants: an observational retrospective studyBlandine Monel, Delphine Planas, Ludivine Grzelak, et al.
Nature Genetics|March 31, 2015
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targetsKornelius Schulze, Sandrine Imbeaud, Eric Letouzé, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2024
Mutational signature, cancer driver genes mutations and transcriptomic subgroups predict hepatoblastoma survivalAurore Pire, Theo Z Hirsch, Guillaume Morcrette, et al.
Hepatology (Baltimore, Md.)|June 18, 2019
Clinical Impact of Genomic Diversity From Early to Advanced Hepatocellular CarcinomaJean-Charles Nault, Yoann Martin, Stefano Caruso, et al.
Journal of Hepatology|February 7, 2026
Serum procalcitonin: A novel tumor biomarker for diagnosis and disease monitoring in fibrolamellar hepatocellular carcinomaJean-Charles Nault, Claudia Campani, Theo Z Hirsch, et al.
Medrxiv : the Preprint Server for Health Sciences|December 3, 2025
Serum Procalcitonin: A Novel Tumor Biomarker for Diagnosis and Follow-Up in Fibrolamellar Hepatocellular CarcinomaJean-Charles Nault, Claudia Campani, Theo Z Hirsch, et al.
Pageof 10